MIP PHARMA DANMARK ApS: Financial statements 2026
CVR: 32886280
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 57,700 and a net result of DKK 26,688 compared with DKK -155,646 the year before. Equity in the 2026 report amounted to DKK -689,995.
- Gross Profit
- DKK 57,700
- Profit/Loss
- DKK 26,688
- Equity
- DKK -689,995
- Total Assets
- DKK 27,619
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 58K | 27K | -690K | 0 |
| 2025 | - | -129K | -156K | -717K | 0 |
| 2024 | - | -92K | -109K | -561K | - |
| 2023 | - | -39K | -65K | -452K | - |
| 2022 | - | -48K | -79K | -387K | - |
Official annual report
Find more companies like MIP PHARMA DANMARK ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2026 annual report, the company had an average of 0 employees. In 2026, the company reported a gross profit of DKK 57,700 and a net result of DKK 26,688 compared with DKK -155,646 the year before. Equity in the 2026 report amounted to DKK -689,995.